Amulya Rajagopal

Amulya Rajagopal practices at Morton Plant Hospital in Clearwater, Florida, part of BayCare Health System.

Amulya Rajagopal's NPI, 1285294355, was assigned on June 19, 2019. Amulya Rajagopal graduated from Wayne State University School Of Medicine in 2019. Amulya Rajagopal holds Florida license ME169051.

Amulya Rajagopal's primary practice is Morton Plant Hospital, at 300 Pinellas St, Clearwater, FL 33756 in Pinellas County. The practice phone is (727) 462-7000.

Amulya Rajagopal's primary practice is Morton Plant Hospital in Clearwater, Florida, part of BayCare Health System. Amulya Rajagopal is also affiliated with BayCare St. Joseph's Hospital. The medical group on file is National Kidney Partners. Dmand AI also links Amulya Rajagopal to 3 more hospitals and 2 dialysis centers, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Amulya Rajagopal practices, 7 sites in all. Vendor and product names are available with a free account.

Nephrology is Amulya Rajagopal's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Amulya Rajagopal is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Amulya Rajagopal's licenses on file in 2 states: Florida and Michigan.

CMS data shows 217 Medicare services from Amulya Rajagopal across 2 procedure codes in 2024, for 88 Medicare patients. Medicare paid $14,826 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 88 Medicare patients who saw Amulya Rajagopal in 2024. The largest group is 65 to 74, with 32 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 25% are also on Medicaid. Their average risk score is 4.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Amulya Rajagopal's median patient age at 72, with 47% women.

In 2024, Amulya Rajagopal wrote 139 Medicare Part D claims for 38 patients. 76% of them were for generic drugs. CMS names the drug for 49 of them, across 3 drugs with 11 or more claims each, at $14,259 in total drug cost. In 2023, CMS named 34 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 42 out of 100 for Amulya Rajagopal for performance year 2024, reported as part of a group. Amulya Rajagopal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Amulya Rajagopal as offering telehealth.

Dmand AI links 2 papers to Amulya Rajagopal in 2014. 2014 was the busiest year, with 2.

CMS Open Payments shows 9 general payments to Amulya Rajagopal from 7 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 86% of the total. Alexion Pharmaceuticals, Inc. paid the most, $238.

Amulya Rajagopal graduated from Wayne State University School Of Medicine in 2019.

Amulya Rajagopal is in network with 12 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.